The onset and progression of multiple sclerosis (MS) is accompanied by changes in brain biochemistry. Magnetic resonance spectroscopy (MRS) is a powerful tool for investigating these changes in vivo. Machine learning analysis of MRS-derived biochemical profiles may reveal metabolic patterns inherent in certain MS subtypes to inform their diagnosis. By employing a feature set of only metabolite concentrations derived from brain MRS data acquired at 7 Tesla, we achieved an 80% validation set accuracy for differentiating MS patients from healthy controls and a 70% validation set accuracy for differentiating relapsing-remitting and progressive MS patients.
This abstract and the presentation materials are available to members only; a login is required.